The National Pharmaceutical Pricing Authority (NPPA), based on June 2025 data, has computed the retail price under paragraph 5 of the Drugs (Prices Control) Order, 2013, for the formulation Each Film Coated Tablet containing Metoprolol Succinate IP 47.5 mg (equivalent to Metoprolol Tartrate ER 50 mg) + Cilnidipine IP 10 mg + Telmisartan IP 40 mg.
The price determination pertains to M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) and M/s Ipca Laboratories Limited (Marketer). After applying the DPCO, 2013 pricing methodology, the worked-out retail price has been calculated at ₹14.35 per tablet (excluding GST), against a claimed price of ₹20.00 (excluding GST).
Accordingly, the proposed retail price for the said formulation has been fixed at ₹14.35 per tablet (excluding GST), ensuring compliance with statutory price control provisions.
